- Home
- KNSA vs BAK Comparison
KNSA vs BAK Comparison
Compare KNSA & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- BAK
- Stock Information
- Founded
- KNSA 2015
- BAK 1972
- Country
- KNSA United Kingdom
- BAK Brazil
- Employees
- KNSA N/A
- BAK N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- BAK Major Chemicals
- Sector
- KNSA Health Care
- BAK Industrials
- Exchange
- KNSA Nasdaq
- BAK Nasdaq
- Market Cap
- KNSA 2.6B
- BAK 952.4M
- IPO Year
- KNSA 2018
- BAK N/A
- Fundamental
- Price
- KNSA $39.14
- BAK $2.51
- Analyst Decision
- KNSA Strong Buy
- BAK Hold
- Analyst Count
- KNSA 7
- BAK 2
- Target Price
- KNSA $49.71
- BAK $4.40
- AVG Volume (30 Days)
- KNSA 564.2K
- BAK 915.3K
- Earning Date
- KNSA 10-28-2025
- BAK 11-10-2025
- Dividend Yield
- KNSA N/A
- BAK N/A
- EPS Growth
- KNSA N/A
- BAK N/A
- EPS
- KNSA 0.47
- BAK N/A
- Revenue
- KNSA $597,973,000.00
- BAK $14,266,076,929.00
- Revenue This Year
- KNSA $62.63
- BAK N/A
- Revenue Next Year
- KNSA $29.93
- BAK $8.62
- P/E Ratio
- KNSA $83.84
- BAK N/A
- Revenue Growth
- KNSA 55.68
- BAK 10.48
- 52 Week Low
- KNSA $17.82
- BAK $2.32
- 52 Week High
- KNSA $42.05
- BAK $6.34
- Technical
- Relative Strength Index (RSI)
- KNSA 57.21
- BAK 44.72
- Support Level
- KNSA $36.56
- BAK $2.39
- Resistance Level
- KNSA $41.28
- BAK $2.77
- Average True Range (ATR)
- KNSA 1.62
- BAK 0.10
- MACD
- KNSA -0.18
- BAK 0.01
- Stochastic Oscillator
- KNSA 62.78
- BAK 42.22
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.